Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief Hero Image

Pharmaceutical & Biotech

Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief

Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population.

Released on Thursday, March 25, 2021
Subscribe to our Newsletter
Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population. Pfizer-BioNTech is primarily producing the vaccine at Pfizer's facility in Kalamazoo, Michigan. Moderna and Johnson & Johnson are contracting out much of their COVID-19 vaccine manufacturing to Catalent, using its facility in Bloomington, Indiana.

As of March 23, about one in four Americans had received at least their first COVID-19 vaccine dose.

Attachment
/iirenergy/industry-news/article.jsp
Share This Article
Want More IIR News?

Make us a Preferred Source on Google to see more of us when you search.

Add Us On Google

Please verify you are not a bot to enable forms.

What is 82 + 2?

Refer This Article


Ask Us

Have a question for our staff?

Submit a question and one of our experts will be happy to assist you.

Explore Our EnergyLive Tools

EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.

Learn More
Related Articles
Explore Our Enery Industry Reports

Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.

Learn More
Industry Intel

Explore Our Coverage

Industries

  • Power Generation
  • Petroleum Refining
  • Natural Gas
  • Natural Gas Liquids
  • Petrochemicals
  • Renewable Fuels

Trending Sectors

  • Data Centers
  • LNG